Structural, chemical and analytical data on controlled substances. The single reference site for forensic drug chemists. Click to login as forendex superuser Southern Association of Forensic Scientitsts
Search for a substance: Help
«CP 47,497»
CSA Names: CP 47,497
CSA Location: Schedule I Section (g) Subsection (1) DEA code 7297
CSA History: S. 3187, 112 Cong., 2nd Sess. added effective 9 Jul 2012
78 FR 664 finalized the prior interim scheduling effective 4 Jan 2013
Names: CP 47,497 (primary)
2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol (IUPAC)
Molecular formula: C21H34O2
Nominal mass: 318
Average mass: 318.4935
Monoisotopic mass: 318.255880
CAS registry number: 70434-82-1
ChemSpider: 10205286
PubChem: 15942731
Wikipedia: CP 47,497
Erowid: Spice Product
Drugs-Forum: CP 47,497
Standard InChI: InChI=1S/C21H34O2/c1-4-5-6-7-13-21(2,3)17-11-12-19(20(23)15-17)16-9-8-10-18(22)14-16/h11-12,15-16,18,22-23H,4-10,13-14H2,1-3H3/t16-,18+/m0/s1
SMILES: CCCCCCC(c1ccc(c(c1)O)[C@H]1CCC[C@H](C1)O)(C)C
Tags: USCSA,cannabinoid,S.3187
Property Value Remarks
Property Value Remarks
Location Type Remarks
CP 47,497 ATR IR.pdf ATR IR Thermo Nicolet
CP47497.pdf EI MS Agilent 5975 MSD
16851-0422988-GCMS.pdf EI MS Agilent 5973 MSD
10889-0430308-GCMS.pdf EI MS para-quinone analog
CP 47497 CCCC No. 10913.pdf SP-GC-IR Solid Phase IR
epi- CP 47497 CCCC No. 10919.pdf SP-GC-IR Solid Phase IR
CP-47, 497 edit.pdf SP-GC-IR DiscovIR
Vendor ID URL
Cayman Chemical 10889 (p-quinonoe analog)
Cayman Chemical 10913
Cayman Chemical 10919 (3-epi)
LGC THC-1187-5
THC Pharm CP 47,497
Tocris Bioscience 3500
Toronto Research Chemicals C781310
Title Publication Date Vol. Iss. Page(s) Remarks
A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide] identified in illegal product Forensic Toxicology 2015-07-01 Vol 33 (367-373) Nahoko Uchiyama et al
Consideration of the major cannabinoid agonists 2009-07-00 Advisory Council on the Misuse of Drugs
Understanding the Spice phenomenon 2009-00-00 European Monitoring Centre for Drugs and Drug Addiction
Further consideration of the synthetic cannabinoids 2012-10-18 Advisory Council on the Misuse of Drugs
GC–MS and FTIR evaluation of the six benzoyl-substituted-1-pentylindoles: Isomeric synthetic cannabinoids Talanta 2014-11-01 Vol 129 (171-182) Forrest T. Smitha et al
Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary Forensic Science International 2012-01-01 Vol 214 (27-32) Péter Jankovics et al
Synthetic cannabinoids and cathinones: prevalence and markets Forensic Science Review 2013-03-01 Vol 25 (7-26) Bretteville-Jensen et al
Identification and analytical properties of new synthetic cannabimimetics bearing 2,2,3,3-tetramethylcyclopropanecarbonyl moiety Forensic Science International 2013-03-10 Vol 226 (62-73) Vadim Shevyrin et al
Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces. 2012-09-01 Loeffler G, Hurst D, Penn A, Yung K
Synthetic cannabinoid and marijuana exposures reported to poison centers Hum Exp Toxicol 2012-10-31 (1006-1011) MB Forrester et al
Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC–MS, NMR analysis and a flash chromato Forensic Science International 2012-07-12 Vol 220 (e17-e22) Bjoern Moosmann et al
Cannabinoid chemistry: an overview Cannabinoids as Therapeutics 2005-01-01 (23-46) Lumír O. Hanuš and Raphael Mechoulam
- SCHEDULING UPDATE - [Synthetic Cannabinoids] Microgram Bulletin 2011-01-00 Vol 44 (1) Proposed Temporary Placement of Five Synthetic Cannabinoids Into Schedule I
Conformational Analysis of the Prototype Nonclassical Cannabinoid CP-47,497 Using 2D NMR and Computer Molecular Modeling J. Med. Chem. 1994-00-00 Vol 37 Xie et al.
Chemical Analysis of Synthetic Cannabinoids as Designer Drugs in Herbal Products For. Sci. Int. 2010-00-00 Vol 198 Uchiyama et al.
Use of High-Resolution Accurate Mass Spectrometry to Detect Reported and Previously Unreported Cannabinomimetics in J. Anal. Toxicol. 2010-06-00 Vol 34 Hudson et al.
JMS Letter: J. Mass Spectrom. 2009-00-00 Vol 44 Auwarter et al.
The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse ACS Chem. Neurosci 2013-00-00 Vol 4 (1081–1092) Samuel D. Banister et al
Isomeric analysis of synthetic cannabinoids detected as designer drugs. DOI: 10.1248/yakushi.131.1141 Yakugaku Zasshi 2011-01-01 Vol 131 (7) Uchiyama N, Kikura-Hanajiri R, Shoda T, Fukuhara K, Goda Y
Identification of Synthetic Cannabinoids in Herbal Incense Blends in the United States J. For. Sci. 2012-09-01 Vol 57 Barry K. Logan et al
Database ID URL
SWGDRUG Mass Spectral Library 526
SWGDRUG Monographs CP 47,497 Monograph,497.pdf
Cayman Spectral Database
Substance name
Substance name
Please send us your comments, questions or suggestions · Collaborate with colleagues at Forendex Forum
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License Updated 3 March 2017